Transition from mild cognitive impairment to normal cognition: Determining the predictors of reversion with multi-state Markov models.
Rubén Sanz-Blasco, José M Ruiz-Sánchez de León, Marina Ávila-Villanueva, Meritxel Valentí-Soler, Jaime Gómez-Ramírez, Miguel A Fernández-Blázquez. Transition from mild cognitive impairment to normal cognition: Determining the predictors of reversion with multi-state Markov models. Alzheimers Dement. 2021 Sep 5. doi: 10.1002/alz.12448. Online ahead of print. PMID: 34482637.
Selecting the most important self-assessed features for predicting conversion to mild cognitive impairment with random forest and permutation-based methods.
Gómez-Ramírez G, Ávila-Villanueva M, Fernández-Blázquez MA. Selecting the most important self-assessed features for predicting conversion to mild cognitive impairment with random forest and permutation- based methods. Scientific Reports 10, Article number: 20630 (2020). PMID: 33244011.
Effects of commonly prescribed drugs on cognition and mild cognitive impairment in healthy elderly people.
Del Ser T, Zea MA, Valentí M, Olazarán J, López-Álvarez J, Rebollo-Vázquez A, Ávila-Villanueva M, Frades B, Medina M, Fernández-Blázquez MA.
J Psychopharmacol. 2019 Aug;33(8):965-974. PMID: 31241413.
Internal Consistency Over Time of Subjective Cognitive Decline: Drawing Preclinical Alzheimer's Disease Trajectories
Ávila-Villanueva M, Maestú F, Fernández-Blázquez MA.
J Alzheimers Dis. 2018 Sep 19. doi: 10.3233/JAD-180307.
The dimensional Structure of Subjective Cognitive Decline. Biomarkers for Preclinical Alzheimer´s Disease.
Fernández-Blázquez MA, Ávila-Villanueva M, Medina M.
Springer Nature. 2018. Vol. 137. Págs: 45-62. ISBN: 978-1-4939-7673-7.
Subjective Cognitive Decline as a Preclinical Marker for Alzheimer's Disease: The Challenge of Stability Over Time
Ávila-Villanueva M, Fernández-Blázquez MA.
(2017) Front Aging Neurosci. 9:377.
Clinical relevance of specific cognitive complaints in determining mild cognitive impairment from cognitively normal states in a study of healthy elderly controls
Ávila-Villanueva M, Rebollo Vázquez A, Ruiz Sánchez de León JM, Valentí M, Medina M, Fernández Blázquez MA.
Fontiers in aging neuroscience. 2016 Sept 20; 8:233. Epub 2016/09.
Specific Features of Subjective Cognitive Decline Predict Faster Conversion to Mild Cognitive Impairment
Fernandez-Blazquez MA, Avila-Villanueva M, Maestu F, Medina M.
Journal of Alzheimer's disease: JAD. 2016 Mar 8; 52(1):271-81. PubMed PMID: 27060949. Epub 2016/04/12.
Psychometric properties of a new short version of the State-Trait Anxiety Inventory (STAI) for the assessment of anxiety in the elderly
Fernandez-Blazquez MA, Avila-Villanueva M, Lopez-Pina JA, Zea-Sevilla MA, Frades-Payo B.
Neurologia (Barcelona, Spain) 2015 Jul-Aug Volume: 30 Issue: 6 Pages: 352-358. PMID: 24484757.
The Vallecas Project: a cohort to identify early markers and mechanisms of Alzheimer's disease
Olazarán J, Valentí M, Frades B, Zea-Sevilla MA, Ávila-Villanueva M, Fernández-Blázquez MA, et al.
Front Aging Neurosci. 2015 Sep; 7. PMID: 26483681.